News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Toyama Chemical Company Says Schering-Plough Corporation Pulls US Antibiotic Filing
August 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, Aug 21 (Reuters) - Japan's Toyama Chemical (4518.T: Quote, NEWS, Research) said on Monday Schering-Plough Corp. (SGP.N: Quote, Profile, Research) has withdrawn its application to U.S. regulators for experimental antibiotic garenoxacin.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
MORE ON THIS TOPIC
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
Editorial
Novo Will Never Beat Lilly. Why Does It Have To?
February 5, 2026
·
3 min read
·
Annalee Armstrong
Earnings
BMS Beats Again Despite Eliquis and Cobenfy Disappointments
February 5, 2026
·
2 min read
·
Dan Samorodnitsky